|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 4/19/18 Procter & Gamble Co 10-Q 3/31/18 71:6.6M |
Document/Exhibit Description Pages Size
1: 10-Q Fy1718 Q3 Jfm 10-Q HTML 897K
2: EX-10.1 Company's Form of Separation Agreement & Release HTML 60K
3: EX-10.2 Company's Form of Separation Letter & Release HTML 39K
4: EX-12 Computation of Ratio of Earnings to Fixed Charges HTML 40K
5: EX-31.1 Rule 13A-14(A)/15D-14(A) Certification Chief HTML 30K
Executive Officer
6: EX-31.2 Rule 13A-14(A)/15D-14(A) Certification Chief HTML 30K
Financial Officer
7: EX-32.1 Section 1350 Certifications Chief Executive HTML 24K
Officer
8: EX-32.2 Section 1350 Certifications Chief Financial HTML 24K
Officer
15: R1 Document and Entity Information HTML 48K
16: R2 Consolidated Statements of Earnings HTML 91K
17: R3 Condolidated Statements of Comprehensive Income HTML 47K
18: R4 Consolidated Balance Sheets HTML 116K
19: R5 Consolidated Statements of Cash Flows HTML 111K
20: R6 Basis of Presentation HTML 25K
21: R7 New Accounting Pronouncements and Policies HTML 35K
22: R8 Segment Information HTML 93K
23: R9 Goodwill and Other Intangible Assets HTML 69K
24: R10 Earnings Per Share HTML 106K
25: R11 Share-Based Compensation and Postretirement HTML 40K
Benefits
26: R12 Risk Management Activities and Fair Value HTML 107K
Measurements
27: R13 Accumulated Other Comprehensive Income (Loss) HTML 52K
28: R14 Restructuring Program HTML 71K
29: R15 Commitments and Contingencies HTML 28K
30: R16 Discontinued Operations HTML 46K
31: R17 Subsequent Event HTML 25K
32: R18 Segment Information (Tables) HTML 93K
33: R19 Goodwill and Other Intangible Assets (Tables) HTML 62K
34: R20 Earnings Per Share (Tables) HTML 106K
35: R21 Share-Based Compensation and Postretirement HTML 37K
Benefits (Tables)
36: R22 Risk Management Activities and Fair Value HTML 110K
Measurements (Tables)
37: R23 Accumulated Other Comprehensive Income (Loss) HTML 50K
(Tables)
38: R24 Restructuring Program (Tables) HTML 66K
39: R25 Discontinued Operations (Tables) HTML 40K
40: R26 New Accounting Pronouncements and Policies - U.S. HTML 43K
Tax Reform (Details)
41: R27 Segment Information (Details) HTML 49K
42: R28 Goodwill and Other Intangible Assets - Change in HTML 44K
the Net Carrying Amount of Goodwill by Global
Business Unit (Details)
43: R29 Goodwill and Other Intangible Assets - HTML 31K
Identifiable Intangible Assets (Details)
44: R30 Goodwill and Other Intangible Assets - Additional HTML 40K
Information (Details)
45: R31 Goodwill and Other Intangible Assets - Additional HTML 25K
Information Other (Details)
46: R32 Goodwill and Other Intangible Assets - Fair Value HTML 34K
Sensitivity (Details)
47: R33 Earnings Per Share (Details) HTML 79K
48: R34 Earnings Per Share - Antidilutive Securities HTML 29K
(Details)
49: R35 Share-Based Compensation and Postretirement HTML 36K
Benefits (Details)
50: R36 Share-Based Compensation and Postretirement HTML 30K
Benefits - Additional Information (Details)
51: R37 Risk Management Activities and Fair Value HTML 30K
Measurements - Assets Measured at Fair Value on A
Recurring Basis (Details)
52: R38 Risk Management Activities and Fair Value HTML 40K
Measurements - Additional Information (Details)
53: R39 Risk Management Activities and Fair Value HTML 38K
Measurements - Derivative Notional Amounts and
Fair Value (Details)
54: R40 Risk Management Activities and Fair Value HTML 28K
Measurements - Derivative Notional Amounts and
Fair Value - Additional Information (Details)
(Details)
55: R41 Risk Management Activities and Fair Value HTML 27K
Measurements - Gain (Loss) on Derivative
Instruments (Effective Portion) (Details)
56: R42 Risk Management Activities and Fair Value HTML 43K
Measurements - Gain (Loss) on Derivative
Instruments (Details)
57: R43 Accumulated Other Comprehensive Income (Loss) - HTML 52K
Changes in Aoci and Reclassification Out of Aoci
(Details)
58: R44 Accumulated Other Comprehensive Income (Loss) - HTML 36K
Net of Tax Expense (Benefit) (Details)
59: R45 Restructuring Program - Additional Information HTML 44K
(Details)
60: R46 Restructuring Program - Restructuring Reserve by HTML 45K
Type of Costs (Details)
61: R47 Restructuring Program - Restructuring Costs Per HTML 41K
Segment (Details)
62: R48 Commitments and Contingencies - Additional HTML 29K
Information (Details)
63: R49 Discontinued Operations - Additional Information HTML 40K
(Details)
64: R50 Discontinued Operations - Additional Information HTML 24K
on Tables (Details)
65: R51 Discontinued Operations - Net Earnings From HTML 55K
Discontinued Operations for Beauty Brands
(Details)
66: R52 Discontinued Operations - Cash Flows for Beauty HTML 37K
Brands (Details)
67: R53 Subsequent Event - Additional Information HTML 26K
(Details)
69: XML IDEA XML File -- Filing Summary XML 123K
14: XML XBRL Instance -- fy1718q3jfm10-qreport_htm XML 1.66M
68: EXCEL IDEA Workbook of Financial Reports XLSX 61K
10: EX-101.CAL XBRL Calculations -- pg-20180331_cal XML 190K
11: EX-101.DEF XBRL Definitions -- pg-20180331_def XML 575K
12: EX-101.LAB XBRL Labels -- pg-20180331_lab XML 1.06M
13: EX-101.PRE XBRL Presentations -- pg-20180331_pre XML 728K
9: EX-101.SCH XBRL Schema -- pg-20180331 XSD 121K
70: JSON XBRL Instance as JSON Data -- MetaLinks 251± 380K
71: ZIP XBRL Zipped Folder -- 0000080424-18-000034-xbrl Zip 225K
| Exhibit |
(1) | I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company; |
(2) | Based on my knowledge,
this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
(3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
(4) | The
registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(5) | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/
JON R. MOELLER |
Vice Chairman and Chief Financial Officer |
Date |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/19/18 | 8-K | ||
| For Period end: | 3/31/18 | |||
| List all Filings | ||||